Skip to main content
. 2023 Mar 15;615(7954):920–924. doi: 10.1038/s41586-023-05812-3

Table 1.

Any-grade treatment-related and TEAEs, regardless of causality

Event Overall population (n = 68)
Any-grade TRAE (5% or over) 53 (77.9%)
   ECG QT prolonged 36 (52.9%)
   Nausea 18 (26.5%)
   Differentiation syndrome 11 (16.2%)
   Vomiting 11 (16.2%)
   Diarrhoea 7 (10.3%)
   Decreased appetite 5 (7.4%)
   Dysgeusia 5 (7.4%)
Any-grade TEAE (20% or over) 67 (98.5%)
   ECG QT prolonged 38 (55.9%)
   Nausea 34 (50.0%)
   Vomiting 27 (39.7%)
   Febrile neutropenia 21 (30.9%)
   Diarrhoea 20 (29.4%)
   Fatigue 18 (26.5%)
   ALT increased 17 (25.0%)
   Headache 16 (23.5%)
   Hyperphosphataemia 16 (23.5%)
   Hypokalaemia 15 (22.1%)
   Hyponatraemia 15 (22.1%)
   Thrombocytopenia 15 (22.1%)
   Epistaxis 14 (20.6%)
   Peripheral oedema 14 (20.6%)

All AEs shown as n (%).

ALT, alanine aminotransferase.